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Ovcrcxprcs~ion of transforming rowth factor pl (TG F,#I) and inere=sed transcription of pro<ollallen type I, an= known to repr~-.~nt major events 
implicated in the development of liver fibros~ under either experimental or ¢lini~l conditions, Here we report that long.term diatary vitamin E 
supplementation i animals undergoing an experimental model of liver fibrosis (indued by chronic treatment of rats with carbon tctmchloridc) 
r~ults in a net inhibition of both h~patic TG F.~I attd =2 (l) pro¢ollagen mRNA levels, Moreo~=r, of striking inter=st is th= obr,¢rvation that vitamin 
E supplementation per so down.modulates basal levels ofTGF,~I mRNA in the liver of untP.atcd animals, =Uitli~tinil that a dietary regimen rich 
in vitamin E may potentially interfere with both the initiation and progression of the fibro~leroti¢ precepting. 
Liver libro~i,=; TGF,~h =2 (I) Pro¢ollaiien: Vitamin E 
1. INTRODUCTION 
Transforming, growth factor-/~l (TGF/~I). a plei- 
otropic pcptide involved in the regulation of cell metab- 
olism and growth, also plays a key role in tissue remod- 
elling following necrosis and inflammation mainly 
through the synthesis of extrncellular matrix compo- 
nents [1-10]. Dur ing the fibrotic response it~ overex- 
pression in the liver is associated with increased tran- 
scription of procollagen type I [11-16], The parallel rise 
of these factors is now generally ac.ccpted as a relevant 
feature of the development of liver fibrosis it l-l 6] and 
finds its explanation in the existenc~ of TGF/~l.acti. 
rated elements in the type I collagen gene [17,18], Ne- 
crosis, inflammation and fibrosis are readily reproduci- 
ble events in the rat during chronic intoxication with the 
prooxidant hepatotoxin carbon tetrachloride (Eel,) 
and such a model is extensively used for experimental 
purposes [8,12,14]. 
W~ have previously shown that dietary vitaznin E 
supplementation, by increasing the liver content of hte 
vitamin, can afford prot~tion a~.ainst liver fibrosis in- 
duced in the rat by chronic treatment with CCI, [i9]. 
This prot~tive ffect of vitamin E is most likely related 
to the antioxidant effect of the vitamin well ehaYacter- 
izeai in the acute model of CCI~ intoxication [20--24], In 
order to investifeate the effect of vitamin E m~mbrane 
Carrespondene= address; G, Pelt, Dipartimento di Medieina nd On- 
cologia Si~rim=ntale. ~z. Patol. Gen, Uni,eetsit'/t di Torino, Corse 
Raffaello 30. 10125 Torino, Italy, Fax: (39)(l 1)65277S3, 
enrichment on liver expression of TGF/~I, the mRNA 
levels of the cytokine as well as of u.2 (I) procollagen 
were determined during CCl,~-indu~d liver fibrosis in 
animals fed either on a standard or on a vitamin E 
supplemented diet. 
2. MATERIALS AND METHODS 
Vitamin E (¢.k¢.,~1~;,¢:ol), g~nidinidm thioc~anat¢, forrrmmide, 
formaldehyde an.,'. ~.alh=r,n s~rm DNA were purchased from Siena 
Chemical company, Eti,kt!um bromide and apro~ gel for el~ctropho- 
rclis were from Bio.Raa fRichmond, California, USA). Yeast RNA 
was from Bo~hrin~r (Mannheim, Germany) whereas odium dodccyl 
sulphate (SDS). carbon tctrachloride and all the other reagents were 
from Merck (Darmstadt, G=rlmany}, Autoradiographic film was pro. 
vidcd by Kodak Ltd,, England, Multiprime DNA la~lling slcttcm kit 
was provided by Amcrsham (Milano, Italy), 
Young male Wistar rats (Nor, san, Corrcyana, Italy). weighing 
50 g at the beginning of the Cxl~rlmm~t. were used, The rats were 
divided initially into two experimental groul~: the first group was fed 
throughout he experiment with a standard pclletted diet (flirt no, 48, 
F, Ill Piotiont, grcscia, Italy) containing 50 mg of vitamin E (as ¢t- 
tocopheryl.actate) per kg of diet (hereafter eferred to as control 
di~t); the second group was fed on the same diet supplemented in 
vitamin E up to 250 ms per ks of diet, After thre~ w=ks of feeding 
the animPl~ of thc~e two ~oul~ (I 30-140 g b.~,~., at this sta@) differed 
only in their hepatic vitamin Econtent that was three tim~s hiller in 
the rats fed on the supplemented diet (90 *_ 1~ vs. 32 ¢ 9 nmol'g liver 
[19]), At this point half of the animals of each group were submittal 
to a cirrhosis induction protocol for 5 weeks ¢s dcrcribe..d by Ehrin- 
preis et al. (animals injeted intml~riton~lly three tim~ a w~k either 
with 0.15 mi of CCl,, diluted in mineral oil, or with the vehicle alone) 
[25]. The rats wet= then ~crifice..d under diethyl ether anaesthesia 24 
h after the last treatment and li,ver sampl~ were immediately frozen 
in liquid nitroi~en and stored at -80"C. 
RNA extraction and Northern blot analysis ware l~rformed as 
follows, Frozen livers were homogenized in a 81~-teflon homogcnlr~r 
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and total RNA was i~lated usin~ a acid ~.uanidinium thiocyan~ted 
phenol/chloroform technique, RNA concentration was dc|ermiPad by 
measurinM the ab~rbanc¢ of the RNA solution at 260 am. Total RNA 
was subjected to elcctrophoresis on a fonnaM¢hyd¢.containinl# l .$~ 
allaro~ i~1 and transferred to a nylon membrane, Membntnes were 
prehybridized for 16- Ill h at 4.2"C in a solution containing ~,  fore'm- 
t ide  (v/vL 5x SSC ~lution pH 7.0 (20x SSC ltotk solution contains 
NaCI l'/,52t% w/v, and sodium citrate g.9'sJ;l,, w/v), 0,1% SDS (w/v), 
Sx Denhardt's, 100,ull/ml salmon sperm DNA, S0Op$/ml yeast RNA. 
Hybridization with "P.lal~lled full.len=th TGF, al and ,,2 (l) procob 
fallen cDNA probes [26.21] was carried out in 50% formamid¢ (Wv), 
5x SSC, 0,1~ $DS (w/vL l x D©nhardt's at 42"C overniihh After 
hyb,'idization membranes were washed with 2 x SSC, 0.5~1, $D$ (wiv) 
for 20 t in  at room temperature nnd with 0,1 x SSC, 0. l~ SDS (w/v) 
for 20 t in  at 52"C, Membranes were expased to ztutoradiollrnphi¢ 
film at -tSO*C with intensifyinll s<r~ns. The =-actin mRNA levels 
were not taken as a r':ferenc¢ since they proved to be 'qron$ly in- 
creeled by the treatment with the hepatotoxin [2El. Aulomdiollrams 
were quantified by densitometri~l scanninll usin~ a la=r d=nqtomctcr 
(LKB 2022 ultrosean) and all values wcrc normalised aitainst the 
relative cthidiun'l bromide stained total RNA, 
W¢=g¢rn blot analysis was f~rformed employinll ;trabbit pol)~lonal 
nntibody that was kindly provided by Dr, Dennis Wan8 (Dept. Phys. 
iololw and Pharmacololw, University of Queensland, Qu~nsland, 
Australia). "['his antibody, croa-rcactitti with rat, was rai~d a~inst 
a peptid¢ corr¢spondiag to ~rboxyterminal l 0 amino acids of human 
TGF,#i, IS0 Pll of proteins of the crude tissue extract obtained by an 
acidic/ethanol procedure according to Assoian et el. [29]. were sub. 
i, ected to a 15~ polyacrylamidc SDS Mcl el~trophor¢fis under rcduc. 
in= conditions [30] and transferred to polyvinyliden¢ difluorid¢ micro- 
porus mcmbran~ usinM a Bio.Rad Trans.Blot Semi Dry Cell [~1], 
• ~ss  bindin@ eapa¢ity of membrant~ was blocked by overniilht irlcu- 
batten at 4"C with S~ bovine serum albumin ia TBS (10 mM Tris.HCl 
pH 7.4, l.'~O mM NaCI). The blots were then incubated ,:uccemdvcly 
with polyclonal antibody diluted h200 for 2 It at room tem~rature, 
with biotinylated antirabbit leg diluted i:2000 ['or I h and. finally, 
with streptavidin-biotinylaled hur~radish peroxidar,¢ complex (Duke 
spur. Milano. Italy). Between incubations the n~embnmmi wcrc washed 
extensively with Tills coataininB 0,1'~ Twecn 20, lmmunoreactiv¢ 
bands were then visualized by reaction with 3,3°.di;tminobenzidin¢. 
The molecular w¢illht marker proteins were Io~lized by brief stainin~ 
of blots with 0,l~, Am ido black in 25~ isopropanol containing I0~ 
acetic acid. 
3. RESULTS AND DISCUSSION 
The protective effect, exerted by vitamin E supple- 
mentation against CC6-induccd liver necrosis is a well 
established event [20-24]. Recently we found that the 
same procedure afforded also protection against fibro- 
sis induced in the male Wistar rat after five weeks of 
chronic CCI+ i.p. dosing [19]. This observation was 
strongly suggestive ofa modulating effect of the natural 
amio~idant in the expression of fibrogenic cytokines. 
As ~h:~w,'. i~ F,.'q, 1. while the steady-~tate level of 
TO"-~I ,nRNA remained low in control rat liver after 
five weeks of intoxication with CC6 there was a four 
times increase in the hepatic amount of TOF/~I mRNA, 
The stimulated expression of the cytokine was petal. 
lclcd in the CC6-treatcd animals by high levels of¢¢2 (I) 
procollagcn mRNA (Fig. 2) that is almost undetectabl¢ 
in normal liver [12]. As already mentioned in the intro- 
duction, the concomitant rise of these two factors repre- 
sents a relevant event in the development of liver fibro- 
sis [11-16], Densitometric s anning of Northern blots 
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FiB. 1. Northern blot analysis of TGF/~I exprcsrdon in fibrotic liver, 
(A) Leveh ofTGF/~I mRNA (bottom panel) in the liver ofcomrol rats 
(lanes a,b) and of ntis treated respectively with CCI. (c.d) and with 
CCi. and vitamin E (=,0. The cthidium bromide.stained =el is shown 
in the top panel. (B) Quantitzttion ofTGl'/~l rngNA h:vcls in the liver 
of control rats (C) and of rats treated respectively with CCI, (CCI,) 
and with CC6 and vitamin E (CC6 + Vii E). Results are ¢xprev=cd as 
percent of the control and arc mean,: _. $,D, of four ~paratc cxi~ri, 
nlents, 
from four separate xperiments showed more than 50% 
decrease in TGFfll mRNA steady-state content in the 
liver of rats receiving a dietary supplementation f m- 
tocophcrol during chronic intoxication with the haloal- 
kan¢ (Fig. I), Together with the reduc¢d expression of 
the cytokine, in the liver of CCI4 treated but ~-tocophc- 
rol supplemented animals the mRNA for al (1) procol- 
lagcn was significantly lowered (approz. 75% as to the 
CC6-treated group taken as I00%, Fig, 2). 
The described antioaidam treatment has been dem- 
onstrated to efficiently counteract the toxic effect of 
carbon tetrachloridc by inhibiting the stimulated oxida- 
tive breakdown of membrane polyunsaturated fatty 
acids [20-24], Thus, our data suggest a role for oxidative 
mechanisms in the stimulation of TGF~I and g2 {I) 
procollagen gcne expression, Consistent with this inter- 
pretation is the stimulation of collagen gcne transcrip- 
tion induced in cultured human foetal fibroblasts by 
268 
Volume 308, number 3 
A 
FEBS LETTERS 
A 
.. " .. 
Aust r ia2  
28 S 
|SS 
28 S 
lBS  
...~:~i ~" .. • 
¢ d 
Cot I 
100 
80 
60 
40 
20 
X00.23..~$ 
I 
CC! 
4 
24,07.P 14,54 
l 
CC/- vit.E 
Fill, 2, Northern blot analysis of a2 ([) procollalien cxpr¢~ion in 
fibrotic liver. (A) Levels of ¢~2 ([) procolla~n (bottom panel) in the 
liver of rats trotted r~pectively with CCh (lanes a.b) and with CCh 
and vitamin £ (c,d), Th, cthidium bromid~ st.'tined gel is shown in the 
top panel, (B)Quantitation of 0r2 (1)procoltagen mRNA Icv¢Is in th¢ 
liver of rats treated r~pcctively with CCL (CCi,d, and with CCh alld 
vitamin E (CCh ÷Vit  E). Rclults arc ,'xprcs~d as percent of the CCh 
group and arc means _+ S,D, of four ~paratc xlxrimcnts. 
ascorbatc dep=ndcnt lipid peroxidation [32] and its inhi- 
bition by ~-tocophcrol and other antioxidants directly 
added to the cell incubation medium [33]. 
On the other hand, one can argue that the lowering 
effect ofot-tocopherol n the TGFFll mRNA levels and 
cons,qucntly on ¢c2 (I) procollagen transcripts i merely 
a cons~ucnc¢ of the prevention of CCl4-induccd necro- 
sis exerted by the vitamin. Even if the latter possibility 
cannot be excluded, the hereafter reported ata on the 
down modulation of basal TGFpl mRNA levels by 
dietary a-tocopherol definitely support a direct action 
of vitamin E on TGF~I expression. Fig. 3 shows the 
Northern blot analysis of TGF~I mRNA extracted 
from the liver of supplemented rats compared to that 
from animals fed the control diet. The results concern- 
ing TGFFll mRNA levels under different experimental 
conditions (see Figs. 1 and 3) are supported by Western 
blot analysis (Figs, 4 and 5). As shown in Fig. 4, using 
purified human TGF~I us a standard (Genzyme Corp,, 
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Fig, 3. Northern blot analysis or TGF,~I expre~ion i normal liver. 
(A) Levels of TGF,a I m RNA (bottom panel)in th~ liver ofcomrol rat., 
(lanes a,b) and of rats tr¢,Rcd with vitamin E (c,d), The cthidium 
bromide-stained $cl is shown in the top panel, (B) Quantitation of
TG |"~fl mR NA levels in the liver of control rats (C) and of rats treated 
with vitamin E (Vit g). Results are cxpr~d as p~rccnt orth¢ control 
and arc m,'ans ¢ S,D. of six ~paratc ¢x~riments, 
Cambridge, MA. USA), under educing conditions, the 
polyclonal antibody employed allowed the detection, as 
the major form, of a polypcptid¢ of 14.45 kDa which 
corresponds tomature monomeric TGFFll. The evalua- 
tion of immunoblots ofthis immunoreactive 14.45 kDa 
peptid¢ in the crude acid liver extracts from different 
experimental groups suggests a pattern of changes in 
agreement with TGFFll mRNA modifications (Fig. 5), 
The high liver con~ntrations of a-toeopherol 
reached by dictary supplementation appear to down- 
modulate the gen¢ expression of a cytokine most likely 
playing a key role in liver fibrogenesis [1!-16]. Even if 
its chain-breaking anlioxidant activity seems likely to be 
involved, the exact molecular mechanisms by which vi- 
tamin E exerts the effects here dc~ribed are yet to be 
clarified. 
The present research will be extended by assessing the 
effect of --tocopherol on the gene expression of other 
fibrogenic ytokines and later on. various human dis- 
cases characterized byfibrotic processes will be consid- 
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FIB. S. Western blot analysis ot iuz-pt, un~r reducing conditions, 
in the crude acid extracts of liver ~mples from dilTercnt exi~rlmental 
groups, /,~vels of immunoreactive TGF,#[ peptide (14,4 kDa) in the 
liver of¢ontrol rats (lanes I and 2), rats treated with vitamin E (lanes 
3 and 4), rats treated chronically with either CCI~ alone (lanes $ and 
6) or with CCI. plus vitamin E (lan~ ? :rod 8). 
• red. In fact, the most important suggestion which can 
"be drawn from the reported ata is th~ possibility to 
control by dietary vitamin E certain pathways responsi- 
ble for th~ initiation and worsening of fibrosis occurring 
not only in the liver but also in the lung, kidney and 
arterial walls. 
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